>
Switch to:

iCo Therapeutics EV-to-Revenue

: (As of Today)
View and export this data going back to 2009. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, iCo Therapeutics's enterprise value is $6.75 Mil. iCo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil. Therefore, iCo Therapeutics's EV-to-Revenue for today is .

During the past 13 years, the highest EV-to-Revenue of iCo Therapeutics was 761.00. The lowest was -12.50. And the median was 59.70.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-01-22), iCo Therapeutics's stock price is $0.047100. iCo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00. Therefore, iCo Therapeutics's PS Ratio for today is .

iCo Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

iCo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

iCo Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

iCo Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where iCo Therapeutics's EV-to-Revenue falls into.


iCo Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

iCo Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.751/0
=

iCo Therapeutics's current Enterprise Value is $6.75 Mil.
iCo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

iCo Therapeutics  (OTCPK:ICOTF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

iCo Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.047100/0
=

iCo Therapeutics's share price for today is $0.047100.
iCo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

iCo Therapeutics EV-to-Revenue Related Terms

iCo Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)